Analysis: Adoption of Adult-Use Legalization Associated with Decrease in State-Level Obesity Rates
FARGO, N.D–(NORML) States that license adult-use marijuana sales may experience a decrease in state-level obesity rates, according to data published in the journal Health Economics.
Researchers affiliated with North Dakota State University compared obesity rates in Washington state following legalization to those of a synthetic control state.
They reported, “Our primary experiment revealed recreational marijuana legalization, which allowed for recreational marijuana dispensaries to open, resulted in decreases in obesity rates for Washington State” as compared to their synthetic control.
Authors concluded, “As more states gravitate to decriminalization, expanded medicinal use, and legalized recreational use of marijuana, our findings provide important insights into contemporary drug policy.”
Case control studies have consistently reported that those with a history of marijuana use are less likely than abstainers to be obese or to suffer from type 2 diabetes. Studies have also previously linked cannabis use to greater rates of physical activity.
Full text of the study, “Assessing the impact of recreational marijuana legalization on obesity,” appears in Health Economics.
Latest News
Cannabis Extraction Market: An In-depth Analysis from 2018-2027
Douglas, Isle Of Man - Cannabis extraction and extract have gone through exponential growth in the past decade. After being criminalized for a long time, the world saw and moved towards legalizing cannabis in many ...
Bright Green Issues Statement of Intent on Illegal Short Selling Activities
GRANTS, N.M. - Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, ...
Global Cannabis Testing Market Analysis Report 2023-2030
DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...